Keyphrases
Beneficial Effects
100%
Glatiramer Acetate
100%
Experimental Autoimmune Neuritis
100%
Multiple Sclerosis
22%
Experimental Autoimmune Encephalomyelitis
22%
Model Experimental
22%
Guillain-Barré Syndrome
22%
Disease Severity
11%
Drug Action
11%
Disease Course
11%
Human Disease
11%
Interaction Terms
11%
Rapid Onset
11%
Route of Administration
11%
Intravenous Route
11%
Peripheral Nerve
11%
Myelin
11%
Repeated Measures Analysis of Variance
11%
Demyelinating Diseases
11%
Onset of Action
11%
Neurophysiological Data
11%
Intraperitoneal Route
11%
Immune Cell Proliferation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Glatiramer
100%
Experimental Autoimmune Neuritis
100%
Disease
33%
Syndrome
22%
Experimental Autoimmune Encephalomyelitis
22%
Multiple Sclerosis
22%
Drug Action
11%
Myelin
11%
Intravenous Route
11%
Demyelinating Disease
11%
Route of Administration
11%
Immunology and Microbiology
Glatiramer Acetate
100%
Experimental Autoimmune Neuritis
100%
Multiple Sclerosis
22%
Experimental Autoimmune Encephalomyelitis
22%
Cell Proliferation
11%
Immunocompetent Cell
11%
Myelin
11%
Drug Mechanism
11%
Peripheral Nerve
11%
Clinically Isolated Syndrome
11%
Neuroscience
Glatiramer Acetate
100%
Neuritis
100%
Multiple Sclerosis
22%
Experimental Autoimmune Encephalomyelitis
22%
Cell Proliferation
11%
Myelin
11%
Peripheral Nerve
11%
Neurophysiology
11%
Demyelinating Disease
11%